Hellenic Dynamics (LSE:HELD) FCF Margin %: 0.00% (As of Sep. 2023)


What is Hellenic Dynamics FCF Margin %?

Hellenic Dynamics LSE:HELD FCF Margin % is 0.00% as of Sep. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hellenic Dynamics's Free Cash Flow for the six months ended in Sep. 2023 was £-1.50 Mil. Hellenic Dynamics's Revenue for the six months ended in Sep. 2023 was £0.00 Mil. Therefore, Hellenic Dynamics's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Hellenic Dynamics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Hellenic Dynamics's FCF Margin % or its related term are showing as below:


LSE:HELD's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.445
* Ranked among companies with meaningful FCF Margin % only.

Hellenic Dynamics FCF Margin % Related Terms

Hellenic Dynamics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Hellenic Dynamics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hellenic Dynamics FCF Margin % Chart

Hellenic Dynamics Annual Data
Trend Dec19 Dec20
FCF Margin %
0.00 0.00

Hellenic Dynamics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep23
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

LSE:HELD vs ZTS, NBIX, VTRS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hellenic Dynamics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hellenic Dynamics FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hellenic Dynamics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hellenic Dynamics's FCF Margin % falls into.


Hellenic Dynamics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hellenic Dynamics's FCF Margin for the fiscal year that ended in Dec. 2020 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2020 )/Revenue (A: Dec. 2020 )
=-0.526/0
= %

Hellenic Dynamics's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-1.497/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Hellenic Dynamics (LSE:HELD) has a FCF Margin % of 0.00% as of Sep. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hellenic Dynamics and its competitors.
Is Hellenic Dynamics' FCF Margin % too high?
Hellenic Dynamics' current FCF Margin % is 0.00%.
How does Hellenic Dynamics' FCF Margin % compare to ZTS and NBIX?
Hellenic Dynamics' FCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Hellenic Dynamics and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hellenic Dynamics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hellenic Dynamics stock overvalued right now?
Hellenic Dynamics (LSE:HELD) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Hellenic Dynamics (LSE:HELD), the current FCF Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hellenic Dynamics Business Description

Address 3 Soothouse Spring, Suite 18 Stanta Business Centre, St. Albans, Hertfordshire, GBR, SW1A 1RN
Hellenic Dynamics PLC is engaged in the cultivation, and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers, destined for the growing medical cannabis markets across Europe.